Company intelligence / Profile preview
Repertoire Immune Medicines
Cambridge, Massachusetts, USArepertoire.com ↗
- Ownership
- Private
- Employees
- ~120
- Development stage
- Phase 1
01
Overview
Repertoire Immune Medicines has advanced a novel multi-clonal T cell therapy into clinical trials for metastatic solid tumors. Its lead program, RPTR‑168, delivers IL‑12 to enhance anti-tumor activity. The company’s DECODE™ platform has demonstrated effectiveness in identifying highly prevalent immunogenic epitopes relevant to both cancer and autoimmunity. Recent partnerships with Genentech and Bristol Myers Squibb validate the breadth of its target discovery capabilities but detailed clinical efficacy results have not yet been published as of May 2025.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- T cell therapies (multi-clonal cytokine-enhanced T cells)TCR bispecific moleculesmRNA cancer vaccinesmRNA tolerizing vaccines
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
Request access →03
Partnerships
Genentech/Roche — collaboration on autoimmune disease therapies using DECODE™ platform ($35M upfront + milestones up to $730M)Bristol Myers Squibb — multi-year strategic collaboration on tolerizing vaccines for autoimmunityJDRF T1D Fund — investment/support for type 1 diabetes program
Beyond the preview
Go deeper on Repertoire Immune Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Repertoire Immune Medicines.